Zacks Research Brokers Reduce Earnings Estimates for Humana

Humana Inc. (NYSE:HUM) – Investment analysts at Zacks Research dropped their Q4 2024 earnings per share estimates for Humana in a research report issued to clients and investors on Wednesday, November 13th. Zacks Research analyst D. Chatterjee now forecasts that the insurance provider will earn ($2.31) per share for the quarter, down from their prior forecast of ($1.64). The consensus estimate for Humana’s current full-year earnings is $15.86 per share. Zacks Research also issued estimates for Humana’s Q3 2025 earnings at $3.72 EPS, Q4 2025 earnings at $0.30 EPS, FY2025 earnings at $16.65 EPS, Q1 2026 earnings at $6.27 EPS, Q2 2026 earnings at $5.51 EPS, Q3 2026 earnings at $2.90 EPS and FY2026 earnings at $14.96 EPS.

A number of other research firms also recently commented on HUM. Leerink Partnrs downgraded shares of Humana from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, October 2nd. Oppenheimer lowered their price objective on shares of Humana from $400.00 to $280.00 and set an “outperform” rating for the company in a research note on Thursday, October 3rd. Cantor Fitzgerald reiterated a “neutral” rating and issued a $395.00 price target on shares of Humana in a report on Tuesday, October 1st. Wells Fargo & Company dropped their target price on Humana from $387.00 to $290.00 and set an “overweight” rating on the stock in a report on Monday, November 4th. Finally, Royal Bank of Canada dropped their target price on Humana from $400.00 to $265.00 and set an “outperform” rating on the stock in a research report on Tuesday, October 8th. Twenty analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and an average target price of $315.86.

Humana Price Performance

Humana stock opened at $271.35 on Monday. The firm has a 50-day moving average of $279.91 and a two-hundred day moving average of $331.59. The company has a debt-to-equity ratio of 0.67, a current ratio of 1.76 and a quick ratio of 1.76. Humana has a 1 year low of $213.31 and a 1 year high of $527.18. The stock has a market cap of $32.67 billion, a price-to-earnings ratio of 24.03, a price-to-earnings-growth ratio of 2.17 and a beta of 0.52.

Humana (NYSE:HUM) last posted its quarterly earnings data on Wednesday, October 30th. The insurance provider reported $4.16 earnings per share for the quarter, topping analysts’ consensus estimates of $3.48 by $0.68. The company had revenue of $29.30 billion for the quarter, compared to analyst estimates of $28.66 billion. Humana had a net margin of 1.18% and a return on equity of 13.20%.

Hedge Funds Weigh In On Humana

Hedge funds have recently made changes to their positions in the stock. Creative Financial Designs Inc. ADV raised its position in Humana by 244.0% in the 3rd quarter. Creative Financial Designs Inc. ADV now owns 86 shares of the insurance provider’s stock valued at $27,000 after purchasing an additional 61 shares in the last quarter. CarsonAllaria Wealth Management Ltd. raised its holdings in Humana by 111.4% during the second quarter. CarsonAllaria Wealth Management Ltd. now owns 74 shares of the insurance provider’s stock worth $28,000 after purchasing an additional 39 shares in the last quarter. Atwood & Palmer Inc. acquired a new position in Humana during the third quarter worth $29,000. Ashton Thomas Securities LLC acquired a new stake in shares of Humana in the third quarter valued at about $31,000. Finally, Your Advocates Ltd. LLP grew its holdings in shares of Humana by 81.8% in the 3rd quarter. Your Advocates Ltd. LLP now owns 100 shares of the insurance provider’s stock worth $32,000 after acquiring an additional 45 shares during the period. Hedge funds and other institutional investors own 92.38% of the company’s stock.

Humana Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, January 31st. Stockholders of record on Tuesday, December 31st will be issued a dividend of $0.885 per share. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.30%. The ex-dividend date is Tuesday, December 31st. Humana’s dividend payout ratio is presently 31.36%.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.